North America accounted for a major share of the global idiopathic pulmonary fibrosis treatment market in 2022. Factors bolstering the market growth include the increasing incidence of idiopathic pulmonary fibrosis and technological advancements in this therapeutic segment. Additionally, product launches and strategic initiatives by key market players significantly contribute to the expansion of the idiopathic […]